JAK/STAT signalling pathway in colorectal cancer: A new biological target with therapeutic implications
Top Cited Papers
- 30 November 2006
- journal article
- editorial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (16), 2668-2670
- https://doi.org/10.1016/j.ejca.2006.07.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- STAT3 as a therapeutic target in head and neck cancerExpert Opinion on Biological Therapy, 2006
- Impact of EGFR expression on colorectal cancer patient prognosis and survivalAnnals Of Oncology, 2005
- Stat5 Synergizes with T Cell Receptor/Antigen Stimulation in the Development of Lymphoblastic LymphomaThe Journal of Experimental Medicine, 2003
- Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a ActivityThe Journal of Experimental Medicine, 2002
- Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell TransformationPublished by Elsevier BV ,2001
- Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cellsOncogene, 2001
- STATs in oncogenesisOncogene, 2000
- Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cellsEuropean Journal of Cell Biology, 2000
- Signal Transducer and Activator of Transcription-3 Serine Phosphorylation by Insulin Is Mediated by a Ras/Raf/MEK-Dependent PathwayEndocrinology, 1997
- STATs and Gene RegulationScience, 1997